HUMAN VACCINIA VIRUS IMMUNE GLOBULIN Pharmacologic Class Indexing
- Class set ID
- b7cd9852-ec1d-4449-b869-2df720782997
- Version
- 2
- Effective date
- 20181113
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
| Label | Manufacturer | Effective | SPL version |
|---|---|---|---|
| These highlights do not include all the information needed to use CNJ-016 ® (vaccinia immune globulin intravenous, human), VIGIV safely and effectively. See full prescribing information for VIGIV. VIGIV (vaccinia immune globulin, human), 5% solution for intravenous use. Initial U.S. Approval: 2005 | Emergent BioSolutions Canada Inc. | 20251216 | 8 |